Home › Funds › AWM Investment Company, Inc. › ABEO

AWM Investment Company, Inc. position in ABEO

ABEONA THERAPEUTICS INC · Health Care

AWM Investment Company, Inc. reported holding 1,487,130 shares of ABEO (ABEONA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$7.8M, representing 0.75% of its reported portfolio and ranking #43 among its reported holdings. AWM Investment Company, Inc. has disclosed ABEO holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)1.49M sh
Reported value held$7.81M
Portfolio Weight0.75%
First reportedQ2 2025
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How AWM Investment Company, Inc.'s ABEO position evolved

AWM Investment Company, Inc. first disclosed a stake in ABEO in Q2 2025 at 470,000 shares (US$2.7M). The position peaked in Q2 2026 at 1,486,130 shares, worth US$9.2M. Across 6 filings, AWM Investment Company, Inc. increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,487,130 shares valued at US$7.8M. Notable position changes include a 42% increase in Q4 2025 (shares fell 15% over the following quarter), a 85% increase in Q2 2026 (shares fell 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 470.00K $2.67M New
Q3 2025 547.00K $2.89M Add
Q4 2025 774.13K $4.08M Add
Q1 2026 803.13K $3.60M Add
Q2 2026 1.49M $9.18M Add
Q3 2026 1.49M $7.81M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABEO and 13F data

ABEO (ABEONA THERAPEUTICS INC) is a Health Care company. 33 other funds we track also report a position in ABEO — the largest reported positions include Cable Car Capital, LP (US$18.6M), AIGH Capital Management LLC (US$15.2M), Propel Bio Management, LLC (US$5.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABEO

All ABEO fund holders →

FAQ

How long has AWM Investment Company, Inc. held ABEO?

AWM Investment Company, Inc. has disclosed ABEO holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is AWM Investment Company, Inc.'s current position in ABEO?

As of Q3 2026, AWM Investment Company, Inc. holds 1.49M shares of ABEO (ABEONA THERAPEUTICS INC), valued at $7.81M, representing 0.75% of its reported portfolio and ranking #43.

Has AWM Investment Company, Inc. been buying or selling ABEO?

In the latest 13F filing (Q3 2026), AWM Investment Company, Inc. held unchanged its position in ABEO. The position peaked in Q2 2026 at 1.49M shares.

Which other funds hold ABEO?

Other major institutional holders of ABEO include Cable Car Capital, LP, AIGH Capital Management LLC, Propel Bio Management, LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.